<?xml version="1.0" encoding="UTF-8"?>
<p id="Par1376">
 <bold>Conclusions:</bold> Results favor the use of Pentaglobin as an adjunctive to antimicrobial treatment for the management of severe infections caused by MDR Gram-negative bacteria. Most of survival benefit was shown in the subgroups of septic shock, age above 60 years, Charlson’s Comorbidity Index above or equal to 3, APACHE II above or equal to 20 and SOFA score above 10. 
</p>
